Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (481-490 of 1,280) with videos related to

Pageof 128
Sort By:
Journal of Hepatology|December 4, 2018
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?Mar Riveiro-Barciela, Eva Muñoz-Couselo, Jesús Fernandez-Sojo, et al.
JHEP Reports : Innovation in Hepatology|July 25, 2022
Corrigendum to 'Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B' [JHEP Reports 3 (2021)]Maria Buti, Maria Stepanova, Adriana Palom, et al.
Tumori|September 23, 2015
Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunderMelissa Bersanelli, Paola Bini, Enrico Rabaiotti, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 26, 2014
[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]María Buti, Blanca Gros, Itziar Oyagüez, et al.
Horticulture Research|October 28, 2015
Molecular genetics and genomics of the Rosoideae: state of the art and future perspectivesSara Longhi, Lara Giongo, Matteo Buti, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2010
Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long-term treatmentD Tabernero, M J Sánchez, M Homs, et al.
Minerva Urology and Nephrology|May 11, 2023
Prognostic models for patients with metastatic urothelial carcinoma: why use them?Michele Maffezzoli, Davide Campobasso, Sara E Rebuzzi, et al.
Immunotherapy|November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysisMatteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
Genome|November 26, 2009
HACRE1, a recently inserted copia-like retrotransposon of sunflower (Helianthus annuus L.)M Buti, T Giordani, M Vukich, et al.
European Journal of Oral Implantology|December 17, 2015
Dental implants with internal versus external connections: 1-year post-loading results from a pragmatic multicenter randomised controlled trialMarco Esposito, Hassan Maghaireh, Roberto Pistilli, et al.
Pageof 128

Showing results (481-490 of 1,280) with videos related to

Sort By:
Pageof 128
Journal of Hepatology|December 4, 2018
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?Mar Riveiro-Barciela, Eva Muñoz-Couselo, Jesús Fernandez-Sojo, et al.
JHEP Reports : Innovation in Hepatology|July 25, 2022
Corrigendum to 'Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B' [JHEP Reports 3 (2021)]Maria Buti, Maria Stepanova, Adriana Palom, et al.
Tumori|September 23, 2015
Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunderMelissa Bersanelli, Paola Bini, Enrico Rabaiotti, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 26, 2014
[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]María Buti, Blanca Gros, Itziar Oyagüez, et al.
Horticulture Research|October 28, 2015
Molecular genetics and genomics of the Rosoideae: state of the art and future perspectivesSara Longhi, Lara Giongo, Matteo Buti, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2010
Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long-term treatmentD Tabernero, M J Sánchez, M Homs, et al.
Minerva Urology and Nephrology|May 11, 2023
Prognostic models for patients with metastatic urothelial carcinoma: why use them?Michele Maffezzoli, Davide Campobasso, Sara E Rebuzzi, et al.
Immunotherapy|November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysisMatteo Santoni, Alessandro Conti, Sebastiano Buti, et al.
Genome|November 26, 2009
HACRE1, a recently inserted copia-like retrotransposon of sunflower (Helianthus annuus L.)M Buti, T Giordani, M Vukich, et al.
European Journal of Oral Implantology|December 17, 2015
Dental implants with internal versus external connections: 1-year post-loading results from a pragmatic multicenter randomised controlled trialMarco Esposito, Hassan Maghaireh, Roberto Pistilli, et al.
Pageof 128